E-LIB Suche - Ergebnisse für: Lamberti, G.

1

Intrapatient variation in PD-L1 expression and tumor mutati..:

Di Federico, A. ; Alden, S.L. ; Smithy, J.W....
Annals of Oncology. , 2024

Link: https://doi.org/10.1016/..

2

Tumor mutational burden for the prediction of PD-(L)1 block..:

Wang, X. ; Lamberti, G. ; Di Federico, A....
Annals of Oncology. 35 (2024) 6 - p. 508-522 , 2024

Link: https://doi.org/10.1016/..

3

Carleson measures for Hardy-Sobolev spaces in the Siegel up..:

Chalmoukis, N. ; Lamberti, G.
Journal of Mathematical Analysis and Applications. 540 (2024) 2 - p. 128635 , 2024

Link: https://doi.org/10.1016/..

4

OA14.04 Three-Year Outcomes with First-Line Pembrolizumab, ..:

Ricciuti, B. ; Arielle Elkrief, A. ; Lin, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S77 , 2023

Link: https://doi.org/10.1016/..

5

OA19.05 Activating MET Tyrosine Kinase Domain Mutations as ..:

Nakazawa, S. ; Pecci, F. ; Ricciuti, B....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S88-S89 , 2023

Link: https://doi.org/10.1016/..

6

Cellular mediators in human leishmaniasis: Critical determi..:

Divenuto, F. ; Marascio, N. ; Quirino, A....
Acta Tropica. 248 (2023) - p. 107037 , 2023

Link: https://doi.org/10.1016/..

7

MA18.09 Carboplatin, Etoposide, Bevacizumab, and Atezolizum..:

Lamberti, G. ; Rihawi, K. ; Riccardi, F....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S168-S169 , 2023

Link: https://doi.org/10.1016/..

8

MA20.06 Association of TTF-1 Expression with Outcomes to Im..:

Di Federico, A. ; Ricciuti, B. ; Alessi, J.V.M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S175 , 2023

Link: https://doi.org/10.1016/..

9

P2.07-03 Factors Associated with Disease Progression after ..:

Pecci, F. ; Thummalapalli, R. ; Alden, S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S323-S324 , 2023

Link: https://doi.org/10.1016/..

10

EP14.01-006 CeLEBrATE: Phase II trial of CarbopLatin, Etopo..:

Andrini, E. ; Lamberti, G. ; Mazzoni, F....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S528-S529 , 2022

Link: https://doi.org/10.1016/..

11

P1.15-03 Clinical Outcomes Among Patients with Non-small Ce..:

Pecci, F. ; Ricciuti, B. ; Alden, S....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S120 , 2022

Link: https://doi.org/10.1016/..

12

EP08.01-043 Clinicopathologic and Genomic Factors Impacting..:

Alessi, J. ; Elkrief, A. ; Ricciuti, B....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S358-S359 , 2022

Link: https://doi.org/10.1016/..

13

T.05.5 ANTIPROLIFERATIVE ACTIVITY OF HIGH DOSE SOMATOSTATIN..:

Magi, L. ; Ricci, C. ; Rinzivillo, M....
Digestive and Liver Disease. 54 (2022) - p. S134 , 2022

Link: https://doi.org/10.1016/..

14

MA02.09 Impact of Baseline Clinicopathologic and Genomic Fe..:

Lamberti, G. ; Ricciuti, B. ; Alessi, J.V....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S49 , 2022

Link: https://doi.org/10.1016/..

15

MA01.08 Impact of [18F]FDG PET/CT-derived Metabolic Paramet..:

Andrini, E. ; Lamberti, G. ; Argalia, G....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S45 , 2022

Link: https://doi.org/10.1016/..